Chrome Extension
WeChat Mini Program
Use on ChatGLM

Metastatic Chordoma with Pancreatic Disease and Response to Imatinib.

Eleanor Klejnow, Katie Hoban,Ioanna Nixon, Thomas Robert Elswood

BMJ case reports(2022)

Cited 1|Views5
No score
Abstract
A 45-year-old woman presented with a left-sided neck swelling following treatment a year prior for cervical spine chordoma. She had initially been managed surgically with a cervical vertebrectomy and a course of proton beam therapy. Although there had been a degree of residual tissue, her disease remained stable radiologically and clinically. Repeat MRI demonstrated an increasing left paravertebral mass and a head of pancreas metastasis, which shared pathological characteristics with chordoma. Given the advanced metastatic nature of her disease, imatinib was offered with a palliative intent. While waiting for treatment she developed a spinal cord compression, managed with radiotherapy. She commenced imatinib and her disease remained stable for 9 months before progressing clinically and radiologically. This case demonstrates an unusual pattern of metastatic chordoma and provides further rationale for imatinib in such patients.
More
Translated text
Key words
cancer intervention,malignant disease and immunosuppression,oncology,pharmacology and therapeutics,tyrosine kinase inhibitor
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined